subcutaneous lesions
Showing 1 - 25 of >10,000
Solid Tumor, Adult, Metastatic Cancer, Soft Tissue Sarcoma Trial in Belgium, France (BT-001, Pembrolizumab [Keytruda])
Recruiting
- Solid Tumor, Adult
- +6 more
- BT-001
- Pembrolizumab [Keytruda]
-
Brussels, Belgium
- +4 more
Jul 13, 2022
Advanced Malignant Solid Tumor, Hepatocellular Carcinoma Trial in Scottsdale (Laboratory Biomarker Analysis, Pharmacological
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- Hepatocellular Carcinoma
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Oct 6, 2021
Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)
Recruiting
- Solid Tumor
- +11 more
- TRK-950
- +14 more
-
Scottsdale, Arizona
- +13 more
Oct 2, 2022
Fibrolamellar Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, DRP-104)
Not yet recruiting
- Fibrolamellar Hepatocellular Carcinoma
-
Baltimore, MarylandJohns Hopkins SKCCC
Aug 30, 2023
Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)
Recruiting
- Metastatic Cancer
- +2 more
- ASP9801
- Pembrolizumab
-
Birmingham, Alabama
- +26 more
Jan 6, 2023
Multiple Sclerosis Trial run by the NINDS (Anakinra)
Recruiting
- Multiple Sclerosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV Trial in Tampa (IFx-Hu2.0)
Completed
- Cutaneous Melanoma, Stage III
- Cutaneous Melanoma, Stage IV
- IFx-Hu2.0
-
Tampa, FloridaH. Lee Moffitt Cancer Center
Aug 5, 2022
Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Worldwide (Ocrelizumab IV, Ocrelizumab SC,
Active, not recruiting
- Relapsing Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Ocrelizumab IV
- +5 more
-
Tampa, Florida
- +46 more
Jan 13, 2023
Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Multiple Sclerosis
- Cladribine Subcutaneous Injection
- 0.9% Chloride Injection Sodium
-
Warsaw, Mazowieckie, PolandInstitute of Psychiatry and Neurology
Jul 26, 2023
Wound Heal, Wound Infection, Wounds and Injuries Trial in Monza (fitostimoline plus)
Recruiting
- Wound Heal
- +2 more
- fitostimoline plus
-
Monza, MB, ItalyBarbara Maglione
Jul 26, 2022
NSCLC With STK11/LKB1 Mutation Trial in New York (Daratumumab and Hyaluronidase-fihj, Pre-Intervention Medication,
Not yet recruiting
- Non-small Cell Lung Cancer With STK11/LKB1 Mutation
- Daratumumab and Hyaluronidase-fihj
- +2 more
-
New York, New YorkNYU Langone Health
Mar 29, 2023
EGFRI Induced Acneiform Lesions Trial in Israel, United States (LUT014 Gel (Dose 1), LUT014 Gel (Dose 2), Placebo)
Recruiting
- EGFRI Induced Acneiform Lesions
- LUT014 Gel (Dose 1)
- +2 more
-
Glendale, California
- +15 more
Dec 29, 2022
Cancer Trial in Næstved (Calcium electroporation)
Recruiting
- Cancer
- Calcium electroporation
-
Næstved, Region Zealand, DenmarkZealand University Hospital
Feb 15, 2022
Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)
Not yet recruiting
- Cutaneous Tumor
- Malignant Solid Tumor
- JCXH-211 Injection
- (no location specified)
Feb 13, 2023
Melanoma Trial in Worldwide (Pembrolizumab Dose C, Pembrolizumab Dose A, Pembrolizumab Dose B)
Active, not recruiting
- Melanoma
- Pembrolizumab Dose C
- +3 more
-
Orange, New South Wales, Australia
- +14 more
Jan 19, 2023
Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled
Active, not recruiting
- Relapsing Remitting Multiple Sclerosis (RRMS)
- Pegylated interferon beta-1a
- Interferon Beta-1A Prefilled Syringe
-
Tehran, Iran, Islamic Republic ofSina Hospital
Feb 5, 2022
Rosacea, Papulopustular Rosacea Trial in Washington (drug, device, other)
Completed
- Rosacea
- Papulopustular Rosacea
- Aminolevulinic acid topical solution 20%
- +2 more
-
Washington, District of ColumbiaMedical Faculty Associates - George Washington University
Dec 1, 2022
Ankle Osteoarthritis Trial in Astana (Injection of biocomposite hydrogel into ankle's cartilage lesion under arthroscopic
Recruiting
- Ankle Osteoarthritis
- Injection of biocomposite hydrogel into ankle's cartilage lesion under arthroscopic control
- Microfracture of ankle's cartilage lesion under arthroscopic control
-
Astana, KazakhstanCenter of National Scientific center Of Traumatology and Orthope
Aug 31, 2023
Keloid Trial in New York (Dupilumab, Placebo)
Recruiting
- Keloid
- Dupilumab
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 16, 2022
Nurse's Role, Patient Compliance, Peristomal Skin Complication Trial in Istanbul (Assigned Interventions STOMA-M)
Completed
- Nurse's Role
- +3 more
- Assigned Interventions STOMA-M
-
Istanbul, TurkeyEylem Toğluk Yiğitoğlu
Dec 22, 2022
Multiple Sclerosis Trial in Worldwide (Mavenclad®)
Completed
- Multiple Sclerosis
-
Sydney, New South Wales, Australia
- +53 more
Jul 25, 2022
Development to Predict Malignant Conversion in Neurofibromatosis
Recruiting
- Neurofibromatosis 1
- +2 more
- Whole Body Magnetic Resonance Imaging
-
Baltimore, MarylandJohns Hopkins University
Dec 22, 2022
Plaque Psoriasis Trial in Xi'an (Tildrakizumab 100 mg, Placebo)
Active, not recruiting
- Plaque Psoriasis
- Tildrakizumab 100 mg
- Placebo
-
Xi'an, ChinaThe First Affiliated Hospital of Air Force Medical University of
Nov 3, 2021